United Kingdom · Who invested in Mereo Biopharma?
Mereo Biopharma's investors include Perceptive Advisors, Janus Henderson Investors, Vivo Capital and Samsara BioCapital.
2022202320242025
$1.5MRound$3.2MRound$6.3MRound$8.4MRound$14MRound$50MRound$2.0MRound$6.2MRound
United Kingdom · Funded startup
Who invested in Mereo Biopharma
Funding summaryUpdated 26 Oct 2026
$92Mraised across 8 rounds since 2021, from 8 sources
$1.5MRound$3.2MRound$6.3MRound$8.4MRound$14MRound$50MRound$2.0MRound$6.2MRound
- Latest round
- Round, $6.2MFeb 2025
- Biggest round
- $50MRound · Jun 2024
- Step-upi
- 3.1×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $1.5M May 2021
- Biggest round
- $50M Round · Jun 2024
- Usual gap between rounds
- 5 months the median of 7
The rounds
- Feb 2025Round$6.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Sept 2024Round$2.0M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jun 2024Round$50M4 new
Source recorded
- Jul 2023Round$14M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jul 2022Round$8.4M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Nov 2021Round$6.3M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jul 2021Round$3.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- May 2021Round$1.5M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Founders and team
From Mereo Biopharma's own website: 15 on the team.
- Dr. Denise Scots-KnightChief Executive Officer
- Bharti NavsariwalaVice President, Head of Regulatory Affairs
- Dr. Ogün SazovaVice President, Clinical Development and Medical Affairs
- Christine FoxChief Financial Officer
- Dr. John LewickiChief Scientific Officer
- Wills Hughes-WilsonChief Patient Access and Commercial Planning
- Charles SermonGeneral Counsel and Business Development
- Dr. Anders EkblomNon-Executive Director
- Dr. Daniel ShamesNon-Executive Director
- Dr. Deepa PakianathanNon-Executive Director
- Dr. Jeremy BenderNon-Executive Director
- Dr. Pierre JacquetNon-Executive Director
- Justin RobertsNon-Executive Director
- Marc YoskowitzNon-Executive Director
- Michael WyzgaChairman
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Round2021Round2021Round2021Round2022Round2023Round2024Round2024Round2025
Perceptive Advisors
Janus Henderson Investors
Vivo Capital
Samsara BioCapital
Perceptive AdvisorsJanus Henderson InvestorsVivo CapitalSamsara BioCapitalEveryone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mereo Biopharma
How much has Mereo Biopharma raised?
Mereo Biopharma has raised $92M across 8 rounds since 2021.
When did Mereo Biopharma last raise?
Mereo Biopharma's most recent round, $6.2M, was in Feb 2025.
What was Mereo Biopharma's biggest round?
Mereo Biopharma's largest round on record is $50M (Undisclosed round), in Jun 2024.
Who backed Mereo Biopharma first?
Mereo Biopharma's first round on record, in Jun 2024, was backed by Perceptive Advisors, Janus Henderson Investors and Vivo Capital and 1 others.
What stage is Mereo Biopharma at?
Mereo Biopharma's latest named round is an Undisclosed round, in Jun 2024.
Where is Mereo Biopharma based?
Mereo Biopharma is based in the United Kingdom.
Companies like Mereo Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.